CTCF and cancer: In six different cancer types, we identified cancer-specific gained and lost CTCF binding sites and showed that gain of CTCF binding in cancer associates with increased chromatin interactions and cancer-specific gene activation, while loss of CTCF binding occurred at promoters of genes present with lower expression in cancer compared to normal cells.